Low-grade developmental and epilepsy associated brain tumors: a critical update 2020

被引:111
|
作者
Slegers, Rutger Juriaan [1 ]
Blumcke, Ingmar [2 ]
机构
[1] Maastricht Univ, Fac Hlth Med & Life Sci, Univ Singel 40, NL-6229 ER Maastricht, Netherlands
[2] Univ Hosp Erlangen, Dept Neuropathol, Schwabachanalge 6, D-91054 Erlangen, Germany
关键词
Pathology; Seizure; Ganglioglioma; Astrocytoma; Oligodendroglioma; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CENTRAL-NERVOUS-SYSTEM; VACUOLATING NEURONAL TUMOR; GENETIC ALTERATIONS; MOLECULAR CHARACTERIZATION; MALIGNANT-TRANSFORMATION; CONSENSUS CLASSIFICATION; EPILEPTOGENIC NEOPLASM; V600E MUTATION; SEIZURES;
D O I
10.1186/s40478-020-00904-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain tumors represent the second most frequent etiology in patients with focal seizure onset before 18 years of age and submitted to epilepsy surgery. Hence, this category of brain tumors, herein defined as low-grade, developmental, epilepsy-associated brain tumors (LEAT) is different from those frequently encountered in adults as (A): 77% of LEAT occur in the temporal lobe; (B): the vast majority of LEAT are of low malignancy and classified as WHO I degrees; (C): LEAT are often composed of mixed glial and neuronal cell components and present with variable growth patterns including small cysts or nodules; (D): LEAT do not share common gene driving mutations, such as IDH1 or 1p/19q co-deletions. Characteristic entities comprise the ganglioglioma (GG), the dysembryoplastic neuroepithelial tumor (DNT), the angiocentric glioma (AG), the isomorphic diffuse glioma (IDG) and the papillary glio-neuronal tumor (PGNT), representing 73.2% of 1680 tumors collected in a large German series of 6747 patients submitted to epilepsy surgery. In the realm of exciting discoveries of genetic drivers of brain tumors new genes have been also reported for LEAT. BRAF V600E mutations were linked to GG with CD34 expression, FGFR1 mutations to DNT, MYB alterations to AG and also IDG and PRKCA fusions to PGNT, suggesting the possibility to also develop a genetically driven tumor classification scheme for LEAT. Rare availability of LEAT in a single center is a challenging obstacle, however, to systematically unravel the neurobiological nature and clinical behavior of LEAT. Other challenges in need of clarification include malignant tumor progression of LEAT entities, seizure relapse in patients following bulk tumor resection and the controversial issue of associated focal cortical dysplasia as additional pathomechanism. In order to advance our understanding and promote reliable diagnostic work-up of LEAT, we recommend, therefore, international collaboration to achieve our goals.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Epilepsy surgery of "low grade epilepsy associated neuroepithelial tumors": A retrospective nationwide Italian study
    Giulioni, Marco
    Marucci, Gianluca
    Pelliccia, Veronica
    Gozzo, Francesca
    Barba, Carmen
    Didato, Giuseppe
    Villani, Flavio
    Di Gennaro, Giancarlo
    Quarato, Pier Paolo
    Esposito, Vincenzo
    Consales, Alessandro
    Martinoni, Matteo
    Vornetti, Gianfranco
    Zenesini, Corrado
    Marras, Carlo Efisio
    Specchio, Nicola
    De Palma, Luca
    Rocchi, Raffaele
    Giordano, Flavio
    Tringali, Giovanni
    Nozza, Paolo
    Colicchio, Gabriella
    Rubboli, Guido
    Lo Russo, Giorgio
    Guerrini, Renzo
    Tinuper, Paolo
    Cardinale, Francesco
    Cossu, Massimo
    EPILEPSIA, 2017, 58 (11) : 1832 - 1841
  • [32] Seizure prognosis of patients with low-grade tumors
    Kahlenberg, Cynthia A.
    Fadul, Camilo E.
    Roberts, David W.
    Thadani, Vijay M.
    Bujarski, Krzysztof A.
    Scott, Rod C.
    Jobst, Barbara C.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2012, 21 (07): : 540 - 545
  • [33] Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges
    Metais, Alice
    Appay, Romain
    Pages, Melanie
    Gallardo, Catherine
    Silva, Karen
    Siegfried, Aurore
    Perbet, Romain
    Maurage, Claude-Alain
    Scavarda, Didier
    Fina, Frederic
    Uro-Coste, Emmanuelle
    Riffaud, Laurent
    Colin, Carole
    Figarella-Branger, Dominique
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (02)
  • [34] Low-grade epilepsy-associated tumors: Epilepsy outcome and antiseizure medication discontinuation after lesionectomies as first-line surgical approach in pediatric population
    Bernardo, Pia
    Scala, Maria Rosaria
    Rubino, Alfonso
    Spennato, Pietro
    Mirone, Giuseppe
    Russo, Carmela
    Santangelo, Pia
    Covelli, Eugenio
    Grimaldi, Giampina
    DOnofrio, Vittoria
    Cinalli, Giuseppe
    EPILEPTIC DISORDERS, 2024, 26 (04) : 460 - 470
  • [35] Alterations in the Brain Microenvironment in Diffusely Infiltrating Low-Grade Glioma
    Torres, Daniela
    Canoll, Peter
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2019, 30 (01) : 27 - +
  • [36] Treatment of Epilepsy Associated with Brain Tumors
    Phi, Ji Hoon
    Chung, Chun Kee
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2010, 53 (07): : 603 - 612
  • [37] Low-grade astrocytoma presenting as brain stone
    Wee, Hsiao-Yue
    Kuo, Jinn-Rung
    Lee, Yao-Lin
    Chen, Tzu-Ju
    Lee, Yi-Ying
    FORMOSAN JOURNAL OF SURGERY, 2014, 47 (06) : 233 - 235
  • [38] Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors
    Hamza, Ameer
    Sirohi, Deepika
    Smith, Steven C.
    Amin, Mahul B.
    ADVANCES IN ANATOMIC PATHOLOGY, 2021, 28 (06) : 396 - 407
  • [39] Pediatric low-grade and ependymal spinal cord tumors
    Merchant, TE
    Kiehna, EN
    Thompson, SJ
    Heideman, RL
    Sanford, RA
    Kun, LE
    PEDIATRIC NEUROSURGERY, 2000, 32 (01) : 30 - 36
  • [40] Extent of Surgical Resection Predicts Seizure Freedom in Low-Grade Temporal Lobe Brain Tumors
    Englot, Dario J.
    Han, Seunggu J.
    Berger, Mitchel S.
    Barbaro, Nicholas M.
    Chang, Edward F.
    NEUROSURGERY, 2012, 70 (04) : 921 - 928